Evaluating the Advantages of Using 3D-Enriched Fragments for Targeting BET Bromodomains.

Publication Type:

Journal Article

Source:

ACS Med Chem Lett, Volume 10, Issue 12, p.1648-1654 (2019)

Abstract:

<p>Fragment-based ligand discovery has been successful in targeting diverse proteins. Despite drug-like molecules having more 3D character, traditional fragment libraries are largely composed of flat, aromatic fragments. The use of 3D-enriched fragments for enhancing library diversity is underexplored especially against protein-protein interactions. Here, we evaluate using 3D-enriched fragments against bromodomains. Bromodomains are highly ligandable, but selectivity remains challenging, particularly for bromodomain and extraterminal (BET) family bromodomains. We screened a 3D-enriched fragment library against BRD4(D1) via H CPMG NMR with a protein-observed F NMR secondary assay. The screen led to 29% of the hits that are selective over two related bromodomains, BRDT(D1) and BPTF, and the identification of underrepresented chemical bromodomain inhibitor scaffolds. Initial structure-activity relationship studies guided by X-ray crystallography led to a ligand-efficient thiazepane, with good selectivity and affinity for BET bromodomains. These results suggest that the incorporation of 3D-enriched fragments to increase library diversity can benefit bromodomain screening.</p>

PDB: 
6UVJ, 6UVM, 6UWX
Detector: 
PILATUS
EIGER
Beamline: 
24-ID-C
24-ID-E